Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Published 13/12/2023, 18:40
Updated 13/12/2023, 20:10
© Reuters.  Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Shares of Despegar.com, Corp. (NYSE: DESP) rose sharply during Wednesday’s session after the company raised its FY23 financial guidance.

The company said it now sees revenue of $690 million to $700 million, versus previous forecast of $670 million to $700 million.

Despegar.com shares gained 16.4% to $9.90 on Wednesday.

Here are some other stocks moving in today's mid-day session.

Gainers

  • Shattuck Labs, Inc. (NASDAQ: STTK) jumped 127.5% to $4.80 after the company announced initial topline dose-expansion data from its ongoing Phase 1A/B clinical trial of SL-172154 in combination with AZA in frontline HR-MDS and TP53m AML patients.
  • ReShape Lifesciences Inc. (NASDAQ: RSLS) shares gained 63.8% to $0.4110 after the company announced it received FDA PMA supplement approval for its next-generation Lap-Band 2.0 FLEX.
  • C4 Therapeutics, Inc. (NASDAQ: CCCC) shares jumped 59% to $3.7199 after the company announced data from the CFT7455 Phase 1 trial in relapsed/refractory multiple myeloma. Following the update, Stifel analyst Bradley Canino upgraded C4 Therapeutics from Hold to Buy and raised the price target from $2 to $12.
  • RiskOn International, Inc. (NASDAQ: ROI) shares gained 38.3% to $0.2016 after declining 9% on Tuesday.
  • Innovative International Acquisition Corp. (NASDAQ: IOAC) shares rose 36% to $11.66.
  • NextPlay Technologies, Inc. (NASDAQ: NXTP) shares gained 26% to $1.1708 after surging 29% on Tuesday.
  • Nephros, Inc. (NASDAQ: NEPH) rose 23% to $3.16.
  • SciSparc Ltd. (NASDAQ: SPRC) gained 21.7% to $5.95 after the company announced results for MitoCareX Bio with its drug discovery platform.
  • Eos Energy Enterprises, Inc. (NASDAQ: EOSE) rose 21% to $1.35. Eos Energy and Pine Gate Renewables announced partnership expansion with a minimum additional volume Of 500MWH.
  • Photronics, Inc. (NASDAQ: PLAB) gained 18.7% to $25.66 following fourth-quarter results.
  • Mynaric AG (NASDAQ: MYNA) shares surged 18.2% to $5.66 after the company received a $33 million order from Northrop Grumman.
  • QuantaSing Group Limited (NASDAQ: QSG) rose 17.2% to $2.4380 following first-quarter results.
  • Professional Diversity Network, Inc. (NASDAQ: IPDN) gained 16% to $2.8899.
  • Aurora Mobile Limited (NASDAQ: JG) shares gained 14% to $2.8254. Aurora Mobile said its subsidiary Wuhan SendCloud Technology Co., Ltd. has entered into a strategic partnership with Beijing Muhua Information Technology Co., Ltd.
  • ABM Industries Incorporated (NYSE: ABM) surged 13.6% to $50.38 after the company reported better-than-expected fourth-quarter financial results and issued guidance.
  • LQR House Inc. (NASDAQ: LQR) rose 9.5% to $1.4126. LQR House announced its new marketing campaign for Soda Jerk.
  • Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) gained 7.4% to $384.03 after the company announced results from its Phase 2 study of VX-548 for the treatment of painful diabetic peripheral neuropathy.
  • REV Group, Inc. (NYSE: REVG) gained 7.3% to $18.31 following upbeat quarterly results.
  • Cal-Maine Foods, Inc. (NASDAQ: CALM) rose 6.3% to $51.96. Cal-Maine has temporarily ceased production at a facility in Kansas following an outbreak of avian influenza at the site.
  • Take-Two Interactive Software, Inc. (NASDAQ: TTWO) shares rose 3.5% to $162.64. Take-Two will be added to the Nasdaq-100 Index, effective prior to market open on Monday, Dec. 18, 2023.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .
Losers
  • Hywin Holdings Ltd. (NASDAQ: HYW) shares fell 46.6% to $3.0001.
  • Boqii Holding Limited (NYSE: BQ) declined 33.3% to $0.6670.
  • Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) fell 32.2% to $0.5497 as the company announced outcomes from meeting with the FDA regarding the company's next Phase 2 study supporting the advancement of next generation capecitabine for cancer patients.
  • Loop Media, Inc. (NASDAQ: LPTV) fell 28.3% to $0.9246 following fourth-quarter results.
  • TC Biopharm (Holdings) Plc (NASDAQ: TCBP) declined 27% to $0.1415. TC BioPharm announced plan to implement ADS ratio change.
  • SRIVARU Holding Limited (NASDAQ: SVMH) fell 25.5% to $0.3051.
  • Wheeler Real Estate Investment Trust, Inc. (NASDAQ: WHLR) fell 24.6% to $0.2637.
  • Green Giant Inc. (NASDAQ: GGE) fell 18.8% to $0.0690. Green Giant recently announced pricing of its public offering.
  • WANG & LEE GROUP, Inc. (NASDAQ: WLGS) fell 16.2% to $0.46 after gaining 7% on Tuesday.
  • Blackboxstocks Inc. (NASDAQ: BLBX) fell 15.8% to $3.24. Blackboxstocks announced it executed a definitive agreement to acquire Evtec Aluminium Limited.
  • IN8bio, Inc. (NASDAQ: INAB) shares fell 10.8% to $1.46 after jumping 28% on Tuesday. IN8bio recently announced updated data from its Phase 1 investigator-sponsored trial of INB-100 in patients with hematologic malignancies.
  • Target Hospitality Corp. (NYSE: TH) declined 11% to $9.74 as the company lowered its FY23 guidance.
  • Medifast, Inc. (NYSE: MED) fell 9% to $68.66. LifeMD announced a strategic alliance with Medifast to offer transformative weight management solution.
  • Pfizer Inc. (NYSE: PFE) declined 8.8% to $26.07 after the company provided FY24 guidance.
  • JetBlue Airways Corporation (NASDAQ: JBLU) fell 6.2% to $5.20.
  • Southwest Airlines Co. (NYSE: LUV) fell 6% to $28.51. Southwest Airlines sees fourth-quarter unit revenues to be down 9%-10% vs. prior view of down 9%-11%.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Now Read This: Don't Miss These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street's Most Accurate Analysts

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.